{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifuhcuur2qeaeyk6ke7zbe7ujkitgt57efmwl4yykwnccsshaeuo4",
    "uri": "at://did:plc:svcthvzunxmjidtlw23zva6n/app.bsky.feed.post/3mhh4qzog52x2"
  },
  "path": "/2026/03/20/crescel-reports-positive-randomized-controlled-trial-results-for-biobotanical-skin-renewal-cream-in-rosacea/",
  "publishedAt": "2026-03-19T21:39:00.000Z",
  "site": "https://laotiantimes.com",
  "tags": [
    "Cision PR Newswire"
  ],
  "textContent": "Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable Tolerability MIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ — Crescel LLC, an innovative science and technology company, today announced results from a double-blind, randomized, active comparator-controlled clinical trial evaluating its biobotanical Skin Renewal Cream compared to a commonly used standard of care—topical metronidazole (Metrocream®) combined with CeraVe® moisturizer—in individuals […]",
  "title": "Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea"
}